drugset / Trial / NCT00354666

Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma

NCT00354666

Phase 2 Completed 20 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study was designed to test safety aspects and effects on lung function of a new dry powder version of GSK159797 for asthmatic subjects to inhale. This will allow comparison with previous studies which have only used inhalation of the drug as a vapour.

Timeline

Start
2004-09
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MILVETEROL Small molecule Inhaled